Brainstorm Cell Therapeutics | BCLI - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Biogen USD 377.7M 433.7M 2026-03
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Cipla INR 7.49B 4.2B 2026-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Mesoblast USD 39.72M 93.81M 2025-12